Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.

Nextech Invest increased its stake in Relay Therapeutics by 855,097 shares; the estimated trade value was ~$6.1 million based on average quarterly pricing. Quarter-end position value rose by $19.7 million, reflecting both new share purchases and stock price moves.